Integrated Core Strategies (US) LLC 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-27 4:00 pm Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 6,292,634 4.300% | -3,107,939 (-33.06%) | Filing |
| 2024-10-11 4:14 pm Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 9,400,573 6.400% | 1,650,440 (+21.30%) | Filing |
| 2024-05-28 4:22 pm Purchase | 2024-05-17 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 7,750,133 5.300% | 7,750,133 (New Position) | Filing |